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Mouse hepatitis virus (MHV)-infected cells contain full-length and subgenomic-length positive- and nega-
tive-strand RNAs. The origin and function of the subgenomic negative-strand RNAs is controversial. In this
report we demonstrate that the synthesis and molar ratios of subgenomic negative strands are similar in
alternative host cells, suggesting that these RNAs function as important mediators of positive-strand synthesis.
Using kinetic labeling experiments, we show that the full-length and subgenomic-length replicative form RNAs
rapidly accumulate and then saturate with label, suggesting that the subgenomic-length negative strands are
the principal mediators of positive-strand synthesis. Using cycloheximide, which preferentially inhibits nega-
tive-strand and to a lesser extent positive-strand synthesis, we demonstrate that cycloheximide treatment
equally inhibits full-length and subgenomic-length negative-strand synthesis. Importantly, following treat-
ment, previously transcribed negative strands remain in transcriptionally active complexes even in the absence
of new negative-strand synthesis. These findings indicate that the subgenomic-length negative strands are the
principal templates of positive-strand synthesis during MHV infection.
Mouse hepatitis virus (MHV), a coronavirus in the Nidovi-
rales order, contains a ;32-kb linear, single-stranded, positive-
polarity RNA genome (8, 21, 28). Upon entry into the cell, the
viral genome is transcribed into seven to eight subgenomic
mRNAs ranging in size from ;1.0 to 32.0 kb (21, 32). The
positive-strand mRNAs are arranged in a 39 coterminal nested
set, and each contains a 59-end ;72-nucleotide leader RNA
sequence which is derived from the 59 end of the genome (20,
37). Leader RNA sequences are joined to body sequences of
each subgenomic-length mRNA at highly conserved intergenic
(IG) sites located just upstream from the coding sequences
of each viral gene (7, 14, 27, 32). In addition to the viral
mRNAs, both full-length as well as subgenomic-length neg-
ative-strand RNAs and replicative form (RF) RNAs have been
detected in porcine transmissible gastroenteritis virus-, bovine
coronavirus-, and MHV-infected cells (13, 30, 32–35). The
subgenomic-length negative-strand RNAs contain antileader
RNA sequences (31, 35). While MHV negative-strand RNA
synthesis is rapidly inhibited by inhibitors of protein synthesis,
positive-strand synthesis is significantly more resistant, suggest-
ing that continued protein synthesis is essential for MHV neg-
ative-strand synthesis (29).
Several discontinuous transcription models have been pro-
posed to explain the presence of leader RNA sequences on
positive-strand RNAs and antileader RNA sequences on full-
length and subgenomic-length negative-strand RNAs (3, 10,
30, 31, 34, 35). It is generally agreed that these smaller RNAs
do not originate from larger precursors (3, 15, 31). The leader-
primed transcription model proposed that a free leader RNA
was synthesized from the 39 end of the full-length minus strand.
In trans, the free leader RNA binds with highly conserved
internal IG elements in a full-length minus-strand template to
prime transcription of each of the subgenomic mRNAs (1, 3, 6,
19, 25). More recently, it was suggested that leader body fusion
might result from quasi-continuous synthesis across looped-out
regions of the template which are brought together by protein-
protein interactions (22, 23). Following primary transcription
of the subgenomic mRNA, these mRNAs may act as templates
for the synthesis of subgenomic-length negative strands con-
taining antileader RNA (34). Nascent labeling experiments
and temperature shift experiments with a temperature-sensi-
tive (ts) mutant defective in negative-strand synthesis strongly
suggest that the subgenomic-length negative-strand RNAs are
transcriptionally active after 6 h postinfection (30, 33). Data
from other groups have suggested that the subgenomic nega-
tive strands may represent dead-end transcriptional products
involved in the synthesis of a single mRNA (16, 24, 40).
It has also been proposed that the subgenomic-length neg-
ative strands may be synthesized directly from the incoming
genomic RNA, either by trans splicing of full-length negative
strands or by transcription attenuation within the IG elements
(3, 22, 23, 30). While trans splicing is less attractive since
full-length replicative intermediates (RIs) cannot be degrad-
ed into subgenomic-length RF RNA (3, 30), the transcription
attenuation model readily accounts for most of the observa-
tions central to coronavirus discontinuous transcription (30).
This model proposes that subgenomic-length negative strands
are synthesized directly from full-length genomic RNA by tran-
scription attenuation within the IG elements. The incomplete
negative strands then act in trans to prime the synthesis of
antileader RNA sequences located at the 59 end of the ge-
nome. Protein protein interactions may also mediate this dis-
continuous transcription event to acquire antileader RNA se-
quences on the subgenomic negative strand (31). Subgenomic
negative strands containing antileader RNAs then serve as the
predominant templates for the synthesis of each equivalently
sized mRNA.
In this study we have used kinetic radiolabeling experiments
and cycloheximide treatment to demonstrate that the sub-
genomic-length negative-strand RNAs function as the princi-
pal templates for mRNA synthesis during MHV infection. The
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implications of these findings for coronavirus transcription are
discussed.
MATERIALS AND METHODS
Virus and cell lines. The A59 strain of MHV (MHV-A59) and the host range
variant MHV-H2 were used throughout these studies. MHV-A59 stocks were
propagated in 150-cm2 flasks containing murine astrocytoma (DBT) cells and
were titered by plaque assay in DBT cells at 37°C (12). The MHV-H2 variant was
selected for growth in Syrian baby hamster kidney cells (BHK) as previously
described by our laboratory (5). MHV-H2 stocks were grown in 150-cm2 flasks of
BHK cells for 40 to 48 h at 37°C and titered by plaque assay in DBT cells.
DBT cells were maintained at 37°C in Eagle’s modified essential medium
(MEM) containing 6% fetal clone II (HyClone Laboratories, Logan, Utah), 5%
tryptose phosphate broth, gentamicin (0.05 mg/ml), and kanamycin (0.25 mg/ml)
(GIBCO). BHK cells were kindly provided by Robert E. Johnston (University of
North Carolina) and propagated at 37°C in aMEM containing 10% fetal calf
serum (FCS), 5% tryptose phosphate broth, gentamicin (0.05 mg/ml), and kana-
mycin (0.25 mg/ml). DDT-1 cells, a Syrian hamster smooth muscle cell line, were
propagated at 37°C in MEM containing 10% FCS, 5% tryptose phosphate broth,
gentamicin (0.05 mg/ml), and kanamycin (0.25 mg/ml). Chinese hamster ovary
cells (CHO) were maintained at 37°C in MEM containing 10% FCS, 5% tryptose
phosphate broth, gentamicin (0.05 mg/ml), and kanamycin (0.25 mg/ml). The
17CL1 cells (kindly provided by Stanley Sawicki) were maintained in MEM
containing 6% FCS, 5% tryptose phosphate broth, and gentamicin (0.05 mg/ml),
and kanamycin (0.25 mg/ml). To reduce virus-induced fusion in the 17CL1 cells,
pH 6.8 medium was used as previously described (30).
Radiolabeling and isolation of viral RNA. Radiolabeling of viral RNAs was
performed in 17CL1, BHK, CHO, or DDT-1 cells. Cultures of cells were seeded
at densities approaching 5.0 3 105 cells/35-mm2 dish and maintained in phos-
phate-free MEM (DMEM) containing 6% fetal clone II, gentamicin (0.05 mg/
ml), and kanamycin (0.25 mg/ml) for 12 to 16 h prior to infection (overnight).
After infection with MHV-A59 or MHV-H2 at a multiplicity of infection (MOI)
of 10 for 1 h at room temperature, the virus inocula were removed and the
cultures were overlaid with DMEM (pH 6.8) containing 2% fetal clone II,
gentamicin (0.05 mg/ml), and kanamycin (0.25 mg/ml). The cultures were main-
tained at 37°C. At least 30 min prior to the addition of radioisotope, the medium
was removed and 100% DMEM containing actinomycin D (AMD) (Sigma) at a
concentration of 10 mg/ml was added to the culture. At the indicated times,
cultures were then radiolabeled with 32Pi (300 mCi/ml) for 1 h to radiolabel
virus-specific mRNA and RI RNAs. The RNA was isolated as described previ-
ously (33).
Kinetic labeling experiments. Cultures of murine 17CL1 cells were seeded at
densities of 5.0 3 105 cells per dish and grown in complete DMEM for 12 to 16 h
(overnight). The cultures were then infected with MHV-A59 at an MOI of 10 for
1 h, virus inocula were removed, and the cultures were incubated in DMEM
containing 2% fetal clone II, gentamicin (0.05 mg/ml), and kanamycin (0.25
mg/ml). At 5 h postinfection, DMEM containing 20 mg of AMD per ml was added
to the cultures. Higher concentrations of AMD were used to reduce background
labeling of cellular RNAs and DNAs associated with the higher concentrations
of radioisotope. At 6.0 h postinfection, cultures were radiolabeled with 32Pi
(1,000 mCi/ml) for 5, 15, 30, 45, and 60 min. After radiolabeling, the monolayers
were washed with cold phosphate-buffered saline and the cells were lysed in LET
buffer (0.1 M LiCl, 0.01 M Tris-HCl [pH 7.4], 0.002 M EDTA [pH 8.0]) con-
taining 50 mg of dodecyl lithium sulfate (LDS) (Fluka) per ml (30, 33). The lysate
was passed through a 26-gauge needle to shear DNA and incubated for 15 min
at 37°C in the presence of proteinase K (200 mg/ml). The RNA was extracted
with an equal volume of low-pH (pH 4.3) phenol (Amresco, Solon, Ohio) by
vortexing for 5 min. After centrifugation for 4 to 5 min in an Eppendorf centri-
fuge, the supernatant was extracted twice with an equal volume of low-pH
phenol-chloroform-isoamyl alcohol (25:24:1) (Amresco) and once with an equal
volume of chloroform. After vortexing for 4 to 5 min, the samples were centri-
fuged in an Eppendorf centrifuge for 4 to 5 min at 12,000 rpm. After the final
extraction, the supernatant was precipitated with 3 volumes of 100% ethanol.
The RNA was collected by centrifugation, dried, and resuspended in sterile,
deionized, diethylpyrocarbonate-treated water for mRNA and RF RNA analysis.
Cycloheximide treatment. Cycloheximide experiments were performed as de-
scribed by Sawicki and Sawicki (29). Briefly, cultures of 17CL1 cells were seeded
at densities of 5.0 3 105 cells/35-mm2 dish and maintained in DMEM containing
6% fetal clone II, gentamicin (0.05 mg/ml), and kanamycin (0.25 mg/ml). The
cultures were infected with MHV-A59 at an MOI of 10 for 1 h at room tem-
perature, virus inocula were removed, and the cultures were incubated in DMEM
containing 2% fetal clone II, gentamicin (0.05 mg/ml), and kanamycin (0.25
mg/ml). At 4 h postinfection, the cultures were treated with AMD (10 mg/ml in
DMEM). Half of the cultures were then treated with cycloheximide (100 mg/ml;
Sigma) for 30 min at 4.5 h postinfection. Cultures were then radiolabeled with
32Pi (300 mCi/ml) for 1 h from 4.5 to 5.5, 6.0 to 7.0, and 7.0 to 8.0 h postinfection.
Following radiolabeling, intracellular RNA was isolated as previously described,
precipitated with ethanol, and resuspended in sterile, diethylpyrocarbonate-
treated deionized H2O (33).
Analysis of viral RNA. Viral mRNA and RF RNA were analyzed as described
by Sawicki and Sawicki (30). Briefly, the RNA (in a total volume of 15 ml) was
treated with 0.16 U of DNase I (Fluka) in 13 DNase buffer (53 DNase buffer
is 500 mM NaCl, 50 mM Tris [pH 7.8], 10 mM CaCl2, and 10 mM MgCl2) for 15
min at 30°C. One-sixth of the total RNA was set aside to be heat denatured at
90°C and analyzed as mRNA. The remaining five-sixths of the sample (in a
volume of 21 ml) was digested with 1.0 ng of RNase A (Worthington) in 13
RNase buffer (33 RNase buffer is 700 mM NaCl, 10 mM Tris [pH 7.4], and 30
mM EDTA [pH 8.0]) for an additional 15 min at 30°C for RF RNA analysis.
Following enzymatic digestion, the RNA was mixed with 2 to 4 ml of 10% LDS
containing 5 mg of proteinase K per ml for 15 min at 30°C and electrophoresed
in 13 TBE (Tris-borate-EDTA)-0.8% agarose gels. The gels were dried under
vacuum before exposure to Hyperfilm-MP (Amersham) at 270°C. Dried gels
containing 32Pi-labeled viral RNAs were scanned for 8 to 12 h by an AMBIS
radioanalytic imaging system (RIS) (Ambis, San Diego, Calif.), and the relative
percent molar ratio of each RNA was calculated from the percentage of total
radiolabel. To calculate the percent molar ratios of mRNA and RF RNA, the
percent counts per minute in each viral RNA was divided by the molecular
weight of the respective mRNA/RF RNA and normalized to 100% (33).
RESULTS
MHV subgenomic RI RNAs are transcriptionally active in
alternative hosts. MHV is generally species specific in vivo and
in vitro, and limited replication with MHV-JHM (;104 PFU/
ml) has been observed in some human cell lines (5, 17). Species
specificity appears mediated at entry since MHV genomic
RNA is infectious and MHV replicates efficiently in nonper-
missive hosts that express the MHV receptor for entry (5, 17).
Using a model system that may be reflective of conditions
present in heavily immunosuppressed xenograph recipients, we
previously isolated an MHV variant (MHV-H2) that replicated
efficiency (107 to 108 PFU/ml) in mouse, hamster, and primate
cell lines (5). It has been suggested that the subgenomic neg-
ative strands represent dead-end products of transcription (16,
24, 40). Accordingly, efficient virus replication in alternative
host species may alter the molar ratio or, perhaps, not require
the synthesis of subgenomic-length negative-strand RNAs. To
test this hypothesis, we characterized the abundance, synthesis,
and regulation of the positive- and negative-strand templates
during MHV-H2 infection in alternative hosts species.
Cultures of 17CL1 cells were maintained in DMEM over-
night and infected with MHV-A59 or MHV-H2. The cultures
were treated with AMD (10 mg/ml) at 5 h postinfection and
radiolabeled with 300 mCi of 32Pi from 6 to 7 h postinfection.
Intracellular RNA was isolated for mRNA and RF RNA anal-
ysis. As shown in Fig. 1A, both the MHV-H2 variant and the
parental virus synthesized six to seven subgenomic mRNAs in
murine cell lines. As previously reported, the MHV-H2 mRNAs
2 and 3 were somewhat smaller than those in MHV-A59,
reflecting the presence of a deletion in the MHV-H2 S glyco-
protein gene (5). Both viruses synthesized full-length and sub-
genomic-length RI RNAs, as evidenced by the presence of
full-length and subgenomic-length RF RNAs in mouse cells.
Following MHV-A59 infection in BHK cell lines, no viral
mRNAs or RF RNAs were observed, consistent with the non-
permissive phenotype of these host cells for wild-type MHV
strains (Fig. 1B). In contrast, seven viral mRNAs and RF
RNAs were detected in MHV-H2-infected BHK cells, effec-
tively linking productive viral infection with the synthesis of
transcriptionally active subgenomic-length negative strands.
Importantly, MHV-H2 mRNA and negative-strand synthesis
were tightly regulated, as the relative percent molar ratio of
each RF RNA generally reflected the abundance of its mRNA
in both 17CL1 and BHK cell lines (Table 1).
To further demonstrate the linkage between efficient
MHV-H2 replication and the synthesis of subgenomic nega-
tive-strand RNAs, transcription was studied in cell lines that
were not used in the selection of the variant. Cultures of CHO
and DDT-1 cells were infected and radiolabeled with 32Pi (300
mCi/ml) between 8 and 9 h postinfection in CHO cells and 17
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to 18 h postinfection in DDT-1 cells. The different labeling
times were chosen to reflect peak levels of viral replication and
to accommodate the delay in MHV-H2 RNA transcription
noted in Syrian hamster DDT-1 cells (5). While MHV-A59
replication was completely restricted in these cell lines, pro-
ductive MHV-H2 replication was always associated with the
synthesis of full-length and subgenomic-length mRNA and RF
RNA (Fig. 2). Similar findings were noted in primate (Vero)
and human (HRT) cell lines (data not shown). Although the
molar ratios of the RF RNAs generally reflected the abun-
dance of each viral mRNAs, a 1-to-1 correlation was often not
noted between a given RF RNA and its mRNA. This variance
is likely due to the times required to synthesize different-sized
mRNA from subgenomic-length templates, i.e., 1 to 2 min to
synthesize the ;1.7-kb mRNA 7 versus 10 to 20 min to syn-
thesize the 32-kb genomic RNA (33). Concentrations of the
smaller subgenomic mRNAs (mRNA 7 especially) accumulate
more rapidly than genomic RNA and the other larger mRNAs,
thereby altering the relative percent molar ratios of each
mRNA. Consequently, percent molar ratios of each positive-
strand RNA generally reflected the relative abundance of each
corresponding subgenomic-length negative-strand RNA and
the time required to transcribe the different-sized mRNA
products from these templates.
Kinetics of MHV full-length and subgenomic-length RI
RNA synthesis. For positive-strand RNA viruses, it is under-
stood that viral mRNA is transcribed from a complementary
negative-strand RNA. Nascent viral RNAs are rapidly radio-
labeled and located in a partially single-stranded, partially dou-
ble-stranded RI RNA (2, 36). Following RNase digestion,
much of the recently transcribed RNA remains affiliated with
double-stranded RF RNA cores (2, 36). Previous studies by
Sethna et al. (34, 35) used probe hybridization to identify the
presence of full-length and subgenomic-length negative-strand
RNAs during transmissible gastroenteritis virus infection.
These experiments could not address whether these negative
strands were templates for mRNA synthesis. Sawicki and
Sawicki used short-pulse-labeling experiments to demonstrate
that full-length and subgenomic-length negative-strand RNAs
were actively transcribing nascent plus strands (31). These ex-
periments, however, were criticized because the subgenomic-
length negative-strand RNAs could be dead-end products of
transcription engaged in the synthesis of a single positive-
strand RNA (16, 33). If negative strands were actively engaged
in continual nascent plus-strand synthesis, both full-length and
subgenomic-length RI RNAs should rapidly incorporate radio-
label, then saturate as the nascent positive strands become
maximally radiolabeled, and then dissociate from the RI com-
plex (36). In contrast, mRNA levels should increase steadily
until degradation and transcription rates become equal.
To study the saturation kinetics of full-length and sub-
genomic-length RI RNAs, cultures of 17CL1 cells were in-
fected with MHV-A59 at an MOI of 10. The cultures were
treated with AMD (20 mg/ml) at 5 h postinfection for 1 h. At
6 h postinfection, the cultures were radiolabeled with 32Pi
(1,000 mCi/ml) for 5, 15, 30, 45, and 60 min. Under these
conditions, nascent positive strands are preferentially labeled
as rates of negative-strand synthesis are reduced at later times
postinfection (29). The intracellular RNAs were isolated and
analyzed for mRNA and RF RNA. Similar to findings reported
by Sawicki and Sawicki (30), increasing amounts of radiolabel
were incorporated into all viral mRNAs following longer la-
beling periods (Fig. 3A). Five-sixths of the intracellular RNA
sample from each labeling period was also treated with DNase
and RNase for RF RNA analysis. In agreement with previous
reports (30, 33), full-length and subgenomic-length RF RNAs
were rapidly labeled after a 5-min pulse, demonstrating that
both full-length and subgenomic-length negative strands were
FIG. 1. MHV-H2 RNA synthesis in murine and hamster cell lines. Cultures
of murine 17CL1 (A) cells and syrian hamster BHK (B) cells were infected with
MHV-A59 or MHV-H2 at an MOI of 10 for 1 h. At 6 and 17 h postinfection
respectively, cultures of 17CL1 cells and BHK cells were labeled with 300 mCi of
32Pi as described in Materials and Methods. Intracellular RNA was isolated from
infected cells and analyzed for the presence of virus-specific mRNAs and RF
RNAs. Lanes: 1, MHV-A59 mRNAs; 2, MHV-H2 mRNAs; 3, MHV-A59 RF
RNAs; 4, MHV-H2 RF RNAs.
FIG. 2. MHV-H2 mRNA and RF RNA synthesis in CHO and DDT-1 cells.
Cultures of CHO and DDT-1 Syrian smooth muscle cell lines were infected with
MHV-H2 at an MOI of 10 for 1 h. At 8 and 17 h postinfection, respectively, the
cultures were labeled with 300 mCi of 32Pi for 1 h. Intracellular RNA was isolated
and treated as described in Materials and Methods and then separated in 0.8%
agarose gels for mRNA (A) and RF RNA (B) analysis. Lanes: 1, CHO cells; 2,
DDT-1 cells.
TABLE 1. Relative percent molar ratios of MHV-H2 mRNA and
RF RNA in BHK, CHO, Vero, and 17Cl-1 cells
RNA species
Relative % molar ratio
mRNA RF RNA
Vero CHO 17Cl-1 BHK Vero CHO 17Cl-1 BHK
1 1.3 0.7 4.5 1.7 4.4 5.2 5.8 3.2
2 6.3 3.4 8.6 5.8 8.5 8.5 11.3 5.9
3 7.8 4.3 6.1 7.1 9.1 6.6 11.2 6.4
4 9.3 7.9 6.4 11.2 11.3 10.6 7.6 12.8
5 10.9 9.2 11.5 12.6 13.8 15.8 11.2 18.0
6 16.0 15.7 18.9 16.5 21.3 21.5 17.4 23.8
7 48.7 58.8 44.1 45.1 30.3 32.4 31.9 30.0
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actively engaged in mRNA synthesis. Increasing amounts of
radiolabel were evident in the RF RNAs with longer labeling
periods (15 to 30 min), after which time the amount of radio-
label slowly increased in the RF RNAs (Fig. 3B). Such findings
were consistent with the hypothesis that the nascent plus
strands on full-length and subgenomic-length RI RNAs rapidly
saturated with label and that all negative strands remained
actively engaged in the synthesis of many new mRNAs.
Saturation kinetics of full-length and subgenomic-length RI
RNAs. If subgenomic-length negative-strand RNAs were dead-
end products of transcription, a linear increase in the amount
of RF RNA should be evident over time as each newly syn-
thesized negative strand synthesized a single positive-strand
RNA and then “burned out” as a double-stranded RF RNA
core. In contrast, if the subgenomic-length negative-strand
RNAs function in transcriptionally active RI RNAs synthesiz-
ing many new nascent positive-strand RNAs, then full-length
and subgenomic-length RI RNAs should generally saturate
with label over time. This is because nascent strands will be-
come fully labeled and then dissociate from the template as
complete mRNAs. The 32Pi-labeled gels in Fig. 3 were scanned
by AMBIS RIS for 8 to 12 h, and the total amounts of radio-
label in each mRNA and RF RNA were quantified. Total
amounts of viral mRNA increased steadily over the labeling
period (Fig. 4A). In contrast rapid increases in total RF RNA
synthesis were evident only during the first 15- to 30-min pulse-
label, after which a gradual linear increase in total RF RNA
levels was evident. The gradual increase in total RF RNA after
30 min was most likely due to the presence of hotter pools of
nucleotide precursors and continued negative-strand synthesis,
which occurs at low levels throughout MHV infection (29–31).
Labeling kinetics of individual MHV full-length and sub-
genomic-length RF RNAs reflected the kinetics of total RF
RNA labeling. Rapid increases in the levels of RF RNA 1 and
RF RNA 7 were noted during the first 30-min pulse-labeling
period, after which total counts in these RF RNAs became
relatively constant. In contrast, total counts in mRNAs 1 and 7
increased steadily over the same labeling period (Fig. 4B). To
provide additional evidence that the full-length and sub-
genomic-length negative-strand RNAs were in transcription-
ally active RI structures, we compared the saturation kinetics
of mRNAs and RF RNAs 1 and 7 over the 1-h time period
(Fig. 5). Importantly, while steady increases in mRNAs 1 and
7 were noted throughout the labeling period, their RF RNAs
rapidly saturated with label. By comparing the percent label
incorporated as a function of total mRNA or RF RNA, satu-
ration kinetics revealed that over 70% of the radiolabel was
incorporated into full-length and subgenomic-length RF
RNAs within 30 min of the addition of label (Fig. 5). Only
slight increases in the amount of RF RNA 1 or 7 were detected
after this time. In contrast, under identical conditions, only
about 15% of the total label was incorporated into mRNA 1 or
7 within the first 30 min. These data were consistent with the
hypothesis that both full-length and subgenomic-length nega-
tive strands remained in transcription-active RI complexes en-
gaged in the continual synthesis of numerous positive-strand
RNAs.
While the slight increase in total levels of the RF RNAs
noted after 30 min was most likely due to new negative-strand
synthesis and hotter pools of nucleotide precursors, this could
also represent RF RNA structures which had burned out and
were accumulating during infection. If this were the case, then
the relative percent molar ratios of the transcriptionally active
full-length RF RNA should decrease over time in proportion
to the low rate of increase in the molar ratios of the slowly
accumulating burned out subgenomic RF RNAs. To address
this possibility, we calculated the percent molar ratio of each
RF RNA and mRNA during the labeling period. Relative
percent molar ratios of the viral mRNAs reflected the relative
abundance of each RF RNA and remained relatively constant
throughout the labeling period as well (Tables 2 and 3). Al-
though insufficient counts were present in some of the larger
mRNAs after the 5-min labeling period, molar ratios of the
mRNAs remained remarkably constant from 15 to 60 min. The
relative percent molar ratio of each RF RNA also remained
nearly constant between 5 and 60 min. It seems likely that the
full-length and subgenomic-length negative-strand RNAs exist
in transcriptionally active RI structures involved in the synthe-
sis of many new nascent positive strands and do not accumu-
late as dead-end products of transcription (Table 3) (10, 30,
33–35).
Subgenomic negative strands remain transcriptionally ac-
tive following cycloheximide treatment. Studies using a ts
mutant defective in negative-strand RNA synthesis have dem-
onstrated that previously transcribed full-length and sub-
genomic-length negative strands remained in transcriptionally
active RI structures engaged in the synthesis of many new
nascent positive strands (33). These findings indicate that sub-
genomic negative strands were transcriptionally active after 6 h
postinfection. To determine if the subgenomic negative strands
functioned as the principal templates for mRNA synthesis, an
alternative approach was developed to assess the function of
the preexisting subgenomic negative strands in the absence of
new negative-strand RNA synthesis. Previous studies by
Sawicki and Sawicki (29) demonstrated that cycloheximide
treatment rapidly inhibited the synthesis of well over 90% of
the new negative-strand RNAs almost immediately after the
addition of the drug to MHV-infected cultures. It was not clear
whether full-length and subgenomic-length negative strands
were equally inhibited by treatment. Positive-strand synthesis
was much more stable and declined slowly over the next few
hours (29).
FIG. 3. MHV mRNA and RF RNA synthesis during MHV infection. Cul-
tures of 17CL1 cells were infected with MHV-A59 at an MOI of 10 for 1 h. The
cultures were treated with AMD and radiolabeled with 1,000 mCi of 32Pi for 5,
15, 30, 45, and 60 min at 6.0 h postinfection. Intracellular RNA was isolated and
treated as described in Materials and Methods for mRNA (A) and RF RNA (B)
analysis in 0.8% agarose gels.
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Cultures of 17CL1 cells were infected with MHV-A59, and
one half was treated with cycloheximide (100 mg/ml) at 4.5 h
postinfection. Cultures were then radiolabeled with 32Pi (300
mCi/ml) from 4.5 to 5.5, 6 to 7, and 7 to 8 h postinfection.
Intracellular RNA was isolated, and the viral mRNAs and RF
RNAs were separated in 0.8% agarose gels. Consistent with
previous finding (29), positive-strand RNA synthesis continued
for at least 3 h after the addition of drug (Fig. 6A). Impor-
tantly, transcriptionally active full-length and subgenomic-
length RF RNAs were evident throughout the labeling period
(Fig. 6B). The gels were scanned by AMBIS RIS for determi-
nation of radioactivity in each mRNA and RF RNA (Fig. 7A
and B). Although cycloheximide treatment rapidly prevented
additional increases of radiolabel into the RF RNAs probably
by blocking new negative-strand RNA synthesis and to a lesser
extent the rate of positive-strand RNA synthesis (29), previ-
ously transcribed negative-strand RNAs remained in transcrip-
tionally active RI RNAs. Cycloheximide treatment also ap-
peared to equally affect the synthesis of new full-length and
subgenomic-length negative strands, as evidenced by reduced
levels of RF RNAs (Fig. 7C). These data indicate that the
subgenomic negative strands remain actively engaged in the
synthesis of many new positive-strand RNAs and likely func-
tion as the principal templates for mRNA synthesis during
MHV infection.
DISCUSSION
Previous studies have clearly demonstrated that a discontin-
uous transcription event is needed to join leader RNA se-
quences located at the 59 end of the MHV genome to the body
sequences of each mRNA (21). Since the seminal observation
that subgenomic-length negative strands were also present in
coronavirus-infected cells, it is less clear whether discontinuous
transcription occurs during positive- or negative-strand RNA
synthesis (13, 34, 35). Subgenomic negative strands may orig-
inate from each corresponding mRNA or from the genome-
length RNA. The function of the subgenomic negative strands
is also unclear, with some laboratories suggesting that they
function as the principal templates for mRNA synthesis (30,
33–35) or represent dead-end products of transcription (16,
40). In this report, we provide additional evidence demonstrat-
ing that the subgenomic-length negative-strand RNAs function
as the principal templates for positive-strand RNA synthesis
during MHV infection.
The xenotropic MHV-H2 host range variant was isolated
from mixed cell cultures of murine and hamster cell lines and
efficiently replicates in murine, hamster, human, and primate
cell lines. Although host range expansion was likely mediated
at the level of entry (5), MHV transcription probably requires
the presence of specific host factors which may regulate the
efficiency of subgenomic RNA synthesis (22, 23, 43). We have
demonstrated that the MHV-H2 variant transcribes both full-
length and subgenomic-length negative-stranded RNAs in mu-
rine, hamster, and human cell lines. The relative percent molar
ratio of each RF RNAs and each corresponding mRNA are
stable and similar in alternative hosts, suggesting that the ratio
of genomic RNA to subgenomic mRNAs is determined by the
relative abundance of the full-length and subgenomic-length
RI RNAs and the time required to synthesize different-sized
mRNAs from these templates. These data also suggest that the
proportion of negative- to positive-strand RNA is tightly reg-
ulated by virally encoded factors. Although these data only
indirectly support a role for the subgenomic negative strands in
FIG. 4. Labeling kinetics of full-length and subgenomic-length RNAs during MHV infection. The gels shown in Fig. 3 were scanned by AMBIS RIS for 12 h, and
radioactivity in each mRNA and RF RNA was determined and plotted as a function of time. (A) Incorporation of label into all seven viral mRNAs and RF RNAs;
(B) radiolabeling kinetics of mRNA 1, mRNA 7, RF RNA 1, and RF RNA 7.
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MHV replication, they confirms earlier findings that the ratio
of genome-length and subgenomic-length negative-strand
RNAs directly influences the relative abundance of each cor-
responding positive-strand RNA (30, 31, 33).
RI RNAs likely contain many actively transcribed nascent
plus strands associated with a single negative-strand template
(2, 3, 36). Studies with Sindbis virus have demonstrated that
RIs rapidly incorporate label and then saturate over time (2,
36). In this report, we demonstrate that the full-length and
subgenomic-length MHV RI RNAs display similar labeling
kinetics and saturate with label as has been described for
alphavirus RI RNAs (2, 36). The relative percent molar ratio
of each RF RNA also remained remarkably constant over the
1-h labeling period, consistent with the hypothesis that both
full-length and subgenomic-length negative strands were ac-
tively engaged in the synthesis of many new mRNAs. Labeling
kinetics were not significantly different between genome-
length and subgenomic-length RI RNAs, refuting the hypoth-
esis that the subgenomic-length negative strands represented
dead-end products of transcription engaged in the synthesis of
a single mRNA. Importantly, the relative abundance of the
subgenomic negative strands reflected the relative molar ratio
of each corresponding mRNA throughout the 1-h labeling
period. Together the data argue that the subgenomic negative
strands function as the principal templates for mRNA synthe-
sis during MHV infection (30, 33–35).
Although previous studies demonstrated that MHV nega-
tive-strand synthesis required continual protein synthesis, it
was not clear whether cycloheximide treatment equally inhib-
ited the synthesis of both full-length and subgenomic-length
negative strands (29). This is important, as an equine arteritis
virus (EAV) replicase mutant which actively transcribes full-
length, but ;100-fold less subgenomic-length, RNAs (plus and
minus) than the wild type has been described (38). These
findings suggest that different viral factors may regulate tran-
scription of full-length and subgenomic-length RNAs in
Nidovirales. Our experiments demonstrate that cycloheximide
FIG. 5. Saturation kinetics of full-length and subgenomic-length RF RNAs.
Radiolabeling kinetics of the MHV viral mRNAs and RF RNAs 1 and 7 were
plotted as a function of percent label in a 1-h labeling period. (A) mRNA and RF
RNA 7; (B) mRNA and RF RNA 1.
FIG. 6. Effect of cycloheximide treatment on full-length and subgenomic-
length mRNA and RF RNA synthesis. Cultures of 17Cl1 cells were infected with
MHV-A59 at an MOI of 10 for 1 h. At 4.5 h postinfection, cycloheximide was
added to one half of the cultures for 30 min; the cultures were radiolabeled with
32Pi (300 mCi/ml) for 1 h at 4.5 to 5.5, 6 to 7, and 7 to 8 h postinfection.
Intracellular RNAs were isolated and treated as described in Materials and
Methods and separated in 0.8% agarose gels. The gels were dried and exposed
to X-ray film. (A) mRNA synthesis; (B) RF RNA synthesis. Lanes: 1, 4.5 to 5.5 h
postinfection without cycloheximide treatment; 2, 6 to 7 h postinfection without
cycloheximide treatment; 3, 7 to 8 h postinfection without cycloheximide treat-
ment; 4, 6 to 7 h postinfection after cyclohixamide treatment; 5, 7 to 8 h
postinfection after cycloheximide treatment.
TABLE 2. Relative percent molar ratios of MHV-A59 mRNAs
over time
mRNA species
Relative % molar ratio
Time (min)
Avg 6 SD
15 30 45 60
1 2.2 1.3 0.8 1.3 1.4 6 0.6
2 6.7 5.9 6.0 6.2 6.2 6 0.4
3 8.2 7.1 7.5 7.9 7.7 6 0.5
4 6.9 13.0 11.4 11.8 10.8 6 2.7
5 9.7 16.4 14.1 14.7 13.7 6 2.9
6 13.5 19.5 19.1 18.8 17.7 6 2.8
7 52.8 36.9 41.1 39.0 42.5 6 7.1
TABLE 3. Relative percent molar ratio of MHV-A59 RF RNAs
over time
RF RNA species
Relative % molar ratio
Time (min)
Avg 6 SD
5 15 30 45 60
1 2.3 3.5 4.3 5.4 6.0 4.3 6 1.5
2 5.9 9.5 11.6 12.6 14.3 10.8 6 3.2
3 5.8 9.4 10.3 10.6 11.7 9.6 6 2.3
4 10.2 12.0 10.1 10.9 9.5 10.5 6 0.9
5 15.3 14.7 13.9 13.8 11.7 13.9 6 1.4
6 23.3 21.3 21.9 20.5 20.9 21.6 6 1.1
7 37.3 29.9 27.6 27.4 26.1 29.7 6 4.5
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treatment rapidly inhibited an increase in both full-length and
subgenomic-length RI RNA, suggesting that continued protein
synthesis was critical for all MHV negative-strand synthesis. If
the MHV negative-strand polymerase is like the EAV enzyme,
then the Nidovirales negative-strand polymerase may consist of
a cycloheximide-sensitive protein factor and one or more ad-
ditional proteins that regulate full- and subgenomic-length
negative-strand synthesis. Importantly, in the absence of new
negative-strand synthesis, these data also show that previously
transcribed full-length and subgenomic-length negative strands
remain actively engaged in the transcription of new mRNAs.
As cycloheximide treatment rapidly inhibits the synthesis of
new negative strands, these data support earlier findings with
MHV ts mutants that demonstrated that preexisting negative
strands remain actively engaged in the synthesis of multiple
new mRNAs (33). Our results clearly support earlier findings
by Sethna et al. (34, 35), Sawicki and Sawicki (30, 31), and
Schaad and Baric (33) and indicate that the subgenomic neg-
ative strands function as the predominant templates for
mRNA synthesis.
The finding of transcriptionally active subgenomic negative
strands does not directly address the mechanism by which
leader RNA sequences are joined to the body sequences of
each subgenomic RNA. However, the leader-primed transcrip-
tion model was heavily based on the presence of full-length
negative strands in infected cells and the presence of sub-
genomic nascent RNAs in the full-length RIs (3, 6, 19). The
former observation is clearly incorrect. The latter findings are
more difficult to interpret in light of recent findings of high-
frequency template switching between nascent RNAs in sub-
genomic-length and full-length RI RNAs during infection (3,
11, 14). Coronavirus-infected cells clearly contain negative-
strand copies of subgenomic mRNA that contain antileader
RNA sequences at their 39 end (35; R. S. Baric et al., unpub-
lished data). The finding of an EAV replicase mutant deficient
in subgenomic negative-strand synthesis further supports the
role of these RNA templates in mRNA synthesis (38). The
origin of these negative-strand RNAs is less clear. Although
transfected mRNAs can function in recombination and repair
of defective MHV genomes, infected cells do not appear to
efficiently replicate these exogenous mRNAs (14, 38; Baric et
al., unpublished data). However, it remains possible that these
mRNAs are not presented in the appropriate context or sub-
cellular compartment to interact with the replication complex
of the virus.
Alternatively, most of the available data supporting the orig-
inal leader-primed transcription model are compatible with the
transcription attenuation model proposed by Sawicki and
Sawicki (30, 31). In this model, the insertion sequence ele-
ments in the genome-length template act as discontinuous
elongation sites that allow for the polymerase and nascent
minus strand to detach and reinitiate transcription (in cis or in
trans) at the 59 end of the genome. This model predicts that all
subgenomic negative strands originate from the genomic RNA
directly, rather than from mRNA. In support of this hypothe-
sis, tandem placement of a coronavirus promoter resulted in
enhanced mRNA synthesis from the downstream-most initia-
tion sites (18). During EAV transcription, the IG element in
subgenomic mRNA is derived from the IG sequences encoded
in the genomic RNA during negative-strand synthesis rather
than from leader sequences encoded at the 59 end of the
genome. These studies support a mechanism of discontinuous
negative-strand synthesis reminiscent of the process of copy
choice RNA recombination (39). Clearly, transcription atten-
uation is an attractive hypothesis which deserves serious atten-
tion, as it is consistent with the available data presented in this
and other reports and represents a more direct mechanism to
regulate subgenomic RNA synthesis (9, 14, 18, 25, 38). Recent
UV transcription-mapping studies with mRNA transcribed
from DI RNAs, however, have suggested that the subgenomic
mRNAs directly originate from genome-length templates (16,
24). Unfortunately, these studies did not directly determine
whether full-length or subgenomic-length templates were func-
tioning during infection.
Additional studies must be designed to directly address the
mechanism by which leader RNA sequences are joined to the
body sequences of subgenomic RNA and determine whether
this occurs from genome-length positive- or negative-strand
RNAs. The presence of transcriptionally active subgenomic-
length negative-strand RNAs provides viruses within the
Nidovirales order not only a unique mechanism to regulate
expression of individual viral genes but also ample opportunity
for rapid evolution by recombination-mediated processes in
the structural genes (4, 11, 26, 41).
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